Financial News
|
Fund Overview
Quote
Performance
|
Chart
Charting
Compare to:
The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings
February 15, 2019
Biotech stocks got some reprieve in this week amid the release of earnings, clinical trial results presentations and positive FDA ... Read More
from Benzinga
Analysts Anticipate 31% Upside For The Holdings of IBB
February 15, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
|
Top News
More News
The Daily Biotech Pulse: Acorda Swings To Profit, Achaogen Offering, Bioblast Strikes Sanfilippo Syndrome Deal
February 15, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Is The Market Like A Rose In A Bubble?
February 14, 2019
The global economy, including China and Europe, has shown signs of a downturn. The U.S. just saw weak retail sales numbers. That is on top of lower business and consumer sentiment. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial
February 14, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Can Granddad Russell 2000 Hold Onto The Bucking Bull?
February 13, 2019
The Russell 2000 is all about manufacturing and supply in the United States. In terms of performance compared to the other 3 indices, it too is a laggard. Read More
from Blogs - TalkMarkets
Battered biotech behind buzzy peanut-allergy therapy says it’s ready to move forward
February 13, 2019
Shares of DBV Technologies took a beating in December, when the biotech withdrew its marketing application for a peanut allergy therapy. Read More
from MarketWatch
Biotech ETFs Could See More Inflows
February 13, 2019
After languishing in the latter stages of 2018, the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund by assets, and the SPDR S&P Biotech ETF (NYSEArca: XBI)... Read More
from ETF Trends
The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering
February 13, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Market Snoozes, But Keep Your Tools Close By
February 11, 2019
It was a choppy session today, which given where the indices sit on the both the Daily and Weekly charts, makes sense. Read More
from Blogs - TalkMarkets
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
February 10, 2019
Biotech stocks held steady in the recent week as earnings from the sector continue to trickle in. The week also saw presentations of ... Read More
from Benzinga
The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs
February 08, 2019
The following are top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week ... Read More
from Benzinga
The Year Of The Pig Sidles Up To The Market Bears
February 07, 2019
So many conflicting signals flying around. Lower interest rates, a stronger dollar, the border wall and the government potentially shutting down, postponed talks with China on the tariffs and an... Read More
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
